Background: IL-4 and IL-13 play a putative role in mucus hypersecretion in
asthma. Suplatast tosilate prevents the synthesis of T-H2 cytokines.
Objective: Because suplatast tosilate inhibits T-H2 cytokines but does not
inhibits IFN-gamma production, we examined the effect of suplatast on IL-4-
or IL-13- and ovalbumin (OVA)-induced mucin synthesis in NCI-H292 cells in
vitro and in bronchi of pathogen-free BALB/c mice in vivo.
Methods: In vitro, NCI-H292 cells were preincubated with suplatast tosilate
(0.1-100 mu g/mL) 1 hour before adding human recombinant IL-4 (10 ng/mL).
In vivo, mouse recombinant IL-4 or IL-13 (250 ng per/mouse) was instilled i
ntranasally in mice pretreated with suplatast tosilate (50 mg(.)kg(-1.)d(-1
)). Mucous glycoconjugates were stained with Alcian blue (AB)/periodic acid
-Schiff (PAS) stain. To evaluate effects of suplatast tosilate on goblet-ce
ll metaplasia in OVA-sensitized mice, animals were pretreated with suplatas
t tosilate (1-50 mg(.)kg(-1.)d(-1)) intragastrically, IL-4 and IL-13 were m
easured, and allergic inflammatory cells were analyzed in bronchoalveolar l
avage fluid of OVA-sensitized mice.
Results: Pretreatment with suplastast did not prevent IL-4- or IL-13-induce
d increase in mucous glycoconjugate production in NCI-H292 cells or in mice
. OVA sensitization increased AB/PAS-stained area of the epithelium (48.1%
+/- 2.4%, P < .01 compared with control mice). Suplatast tosilate inhibited
OVA-induced goblet-cell metaplasia in airway epithelium in a dose-dependen
t fashion; 50 mg(.)kg(-1.)d(-1) decreased the AB/PAS area to 22.7% +/- 2.7%
(P < .05 compared with OVA sensitization alone). Pre-treatment with suplat
ast tosilate also prevented OVA-induced increase in IL-4 and IL-13 levels a
nd decreased the number of lymphocytes and eosinophils in bronchoalveolar l
avage fluid (P < .05 compared with values of mice given OVA alone),
Conclusion: These results indicate that suplatast tosilate prevents allerge
n-induced goblet-cell metaplasia and the recruitment of eosinophils and lym
phocytes into the airways, These results suggest that this effect is due to
the prevention of the production of T-H2 cytokines in airways.